SURFACTANT PROTEIN (SP) B is a 79-amino acid amphipathic peptide produced by the proteolytic cleavage of surfactant proprotein (proSP) B in type II epithelial cells in the alveoli of the lung. The SP-B peptide is stored in lamellar bodies and secreted with phospholipids into the airway lumen. The function of SP-B is to stabilize the surfactant membrane layer and facilitate the spreading of phospholipids, preventing collapse during the respiratory cycle. SP-B is an essential component of surfactant and is required for postnatal respiratory adaptation (43) . Mutations in the SP-B gene in both humans and mice cause respiratory failure after birth (8, 29, 30) .
It has been well established that retinoic acid (RA) receptors (RARs) play critical roles in proliferation, differentiation, and apoptosis in a variety of epithelial cells. Recently, RAR-␣ and -␥ and retinoid X receptor (RXR)-␣ were detected in the H441 cell line, which is derived from pulmonary adenocarcinoma epithelial cells. In H441 cells, RA and RARs stimulated SP-B promoter activity, mRNA accumulation, and protein production (12, 13, 45) . Increases in SP-B mRNA and protein accumulation in fetal lung explants have also been observed (2, 28) . RA stimulation of the human (h) SP-B gene is mediated through direct binding of the RAR/RXR heterodimer to the SP-B promoter (45) . The region between Ϫ375 to Ϫ500 bp of the hSP-B promoter was identified as the responsible sequence for RAR binding and transactivation (45) .
Lung development is dependent on expression of RARs (10, 26) . RAR-␣, -␤, and -␥ belong to the superfamily of nuclear receptors. They form heterodimers with the RXR, bind to the RA response element (RARE) on promoter regions of target genes, and exert stimulatory effects after binding to their ligand RAs (19, 21, 22) . Expression of all three isotypes of RAR was previously detected in the developing lung by in situ hybridization or RT-PCR in the mouse and rat (10, 25) . RAR-␣ and -␤ null mutant mice died in utero and had severely hypoplastic lungs (26) . Lung organogenesis is dependent on interactions between mesenchymal and epithelial cells. Several studies (3, 6, 28) in lung buds indicated that lung branching morphogenesis and differentiation were strongly influenced by RA in vitro. Recent studies (23, 24) demonstrated that RA also influences alveolarization. Treatment of rats with all trans-RA increased the number of alveoli and reversed an alveolar disorder caused by elastase-induced pulmonary emphysema in animals (23, 24) .
RARs consist of a DNA binding domain that contains Zn 2ϩ finger motifs, ligand binding and dimerization domains, a ligand-independent transcriptional activation (AF-1) domain, a ligand-dependent transcriptional activation (AF-2) domain, and an F region (19, 21, 22) . Through these various domains, RARs interact with other transcriptional and signaling cofactors, including p160/SRC-I/TIF-II/Rac-III, CBP/p300, AP-1, TFIIH, and TAF II 135 (7, 15, 16, 18, 27, 31, 35, 39, 42) . Through structure-function studies, dominant negative mutants of RARs have been developed and characterized (9, 11) . Removal of the COOH-terminal AF-2 domain of RARs yields dominant negative mutant receptors in cultured animal cells. The integrity of both the DNA binding and heterodimerization functions of RARs is required for the dominant negative effect. The dominant negative mutant of RAR-␣ blocks wild-type RAR function and has been successfully used in transgenic mice (17) .
To further elucidate the biological functions and mechanism of RAR-␣ in the regulation of hSP-B gene expression, a dominant negative mutant, hRAR-␣403, was generated and expressed in H441 cells with a mammalian cell expression vector. This was based on an observation that RAR-␣ was detected on day 14.5 of gestation in the fetal mouse lung. The mutant RAR-␣ The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
protein was expressed in H441 cells and localized to the nucleus. The mutant hRAR-␣403 protein retained DNA binding activity on the RARE of the hSP-B promoter. Cotransfection of the mutant hRAR-␣403 strongly inhibited transcription of the hSP-B promoter by luciferase reporter assay and proSP-B production in H441 cells.
METHODS AND MATERIALS
Cell culture. Human pulmonary adenocarcinoma (H441) cells were cultured in RPMI 1640 medium (GIBCO BRL, Grand Island, NY) supplemented with 10% fetal calf serum, glutamine, and penicillin-streptomycin. Cells were maintained at 37°C in 5% CO 2 -air and passaged weekly.
Plasmid constructs. The hSP-B 500-bp promoter (hSP-B-500) was made as previously described (46) . hRAR-␣403-FLAG was generated by PCR with synthetic oligonucleotide primers, with an hRAR-␣/pSG5 construct as a template (kindly provided by Dr. Pierre Chambon, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strassbourg, France). The upstream primer with the EcoR I site and the Kozak sequence was 5Ј-GCGGAATTCGCCACCATGGCCAGCAACAGCAGCTCC-3Ј. The downstream primer with the Xba I site and the FLAG sequence (underlined) was 5Ј-CTCGCTCTAGATTATCA-CTTGTCATCGTCGTCCTTGTAGTCCGGGATCTCCATCTT-CAGCGT-3Ј. The PCR products were digested with EcoR I and Xba I restriction enzymes and ligated with EcoR I-Xba I-digested PCR3.0 luciferase reporter plasmid that contains the cytomegalovirus (CMV) promoter (Invitrogen, Carlsbad, CA). The correctness of hRAR-␣403-FLAG/PCR3.0 was confirmed by DNA sequencing. hRAR-␣462-FLAG/PCR was generated the same way except that the downstream primer was 5Ј-CTCGCTCTAGATTATCACTTGTCATCGTCGTCCTTGTA-GTCCGGGGAGTGGGTGGCCGGGCT-3Ј. All primers were made by GIBCO BRL.
In vitro transcription, translation, and Western blot analysis. hRAR-␣403-FLAG/PCR3.0 and hRAR-␣462-FLAG/PCR3.0 were transcribed and translated with the TNT T7 Quick Coupled Transcription/Translation System (Promega, Madison, WI) at 30°C for 90 min. As a positive control, thyroid transcription factor (TTF)-1-FLAG/PCR3.0 was also transcribed and translated. The negative control was the PCR3.0 empty vector. The programmed products were separated on a 10% polyacrylamide gel and subsequently transferred to a nitrocellulose membrane. Western blot analysis with an anti-FLAG monoclonal antibody was performed as described previously (14) .
Electrophoretic mobility shift assay. A previously described RARE oligo probe of the hSP-B promoter was used for an electrophoretic mobility shift assay (EMSA) study (45) . In vitro transcribed and translated hRAR-␣403 and hRXR-␥ proteins were incubated with the radiolabeled probe and separated by 4% nondenaturing gel as described previously (46) . Antibody recognizing RAR (5 µg; Santa Cruz Biotechnology, Santa Cruz, CA) was used for identifying the hRAR-␣403/ hRXR-␥ complex in an EMSA study.
Transient transfection and luciferase assays. Cotransfection of hRAR-␣403-FLAG with hSP-B-500 and a luciferase assay were performed in H441 cells as previously described (45, 47) . The pCMV-␤-Gal plasmid was cotransfected for normalizing transfection efficiency. Each experiment was repeated at least three times. Significance of the inhibitory effects of hRAR-␣403-FLAG was determined by one-way ANOVA with the SigmaStat program.
Immunohistochemistry and immunofluorescent staining. Immunohistochemical staining of H441 cells transfected with hRAR-␣403-FLAG/PCR3.0, hRAR-␣462-FLAG/PCR3.0, and TTF-1-FLAG/PCR3.0 with the anti-FLAG antibody (Kodak, New Haven, CT) was performed as previously described (45) . In the control cells, no specific antibody was added. Immunofluorescent staining of H441 cells transfected without and with hRAR-␣403-FLAG/PCR3.0 was performed as previously described (14) . Expression of hRAR-␣403-FLAG/PCR3.0 was detected with the anti-FLAG antibody and Texas Redconjugated goat anti-rabbit secondary IgG (Jackson ImmunoResearch Laboratories, West Grove, PA). Expression of proSP-B was detected with a proSP-B polyclonal antibody and FITC-conjugated goat anti-mouse IgG secondary IgG (Jackson ImmunoResearch Laboratories). All trans-RA was purchased from Sigma (St. Louis, MO).
RESULTS

Expression of RAR-␣ in developing lung.
We previously detected RAR-␣ expression in respiratory epithelial H441 cells. To assess which isoforms of RAR are expressed in the developing lung, tissue sections from a fetal mouse lung on day 14.5 of gestation were immunohistochemically stained with an antibody recognizing RAR-␣. Figure 1 shows staining of RAR-␣ in the epithelium of the developing mouse fetal lung by the anti-RAR-␣ polyclonal antibody. Based on this result, the ␣ isotype of RAR was chosen to make a dominant negative mutant for further study of the hSP-B promoter.
Construction of dominant negative hRAR-␣403-FLAG.
To test whether expression of a dominant negative mutant of RAR-␣ inhibited the hSP-B promoter, the mutant hRAR-␣403-FLAG and the wild-type hRARa462-FLAG were inserted into the mammalian expression vector PCR3.0 as illustrated in Fig. 2 . The mutant contains the AF-1, DNA binding domain, and ligand binding and dimerization domains of hRAR-␣ but lacks the AF-2 and F domains. A Kozak sequence (ACCATGTCG) was included at the NH 2 terminus of hRAR-␣403 and hRAR-␣462 to enhance the efficiency of translation. A FLAG sequence was included at the COOH terminus of hRAR-␣403 and hRAR-␣462 and 
Expression of hRAR-␣403-FLAG and hRAR-␣462-FLAG in vitro.
To test whether the hRAR-␣403-FLAG/ PCR3.0 and the wild-type hRAR-␣462-FLAG/PCR3.0 vectors generated protein products of correct sizes, the constructs were transcribed and translated in vitro in the rabbit reticulocyte lysate system. The products of the programmed lysates were separated on a 10% polyacrylamide gel and analyzed by Western blot with the anti-FLAG antibody. Both the full-length hRAR-␣462-FLAG and the short-form hRAR-␣403-FLAG were produced in the reticulocyte lysate system (Fig. 3) . Because TTF-1-FLAG/PCR3.0 was well characterized previously (14) , it was also transcribed and translated in vitro as a positive control. In the negative control, the reticulocyte lysate revealed no FLAG fusion protein.
Expression of hRAR-␣403-FLAG in H441 cells. Expression of the hRAR-␣403-FLAG and hRAR-␣462-FLAG vectors in H441 cells was assessed. The constructs hRAR-␣403-FLAG/PCR3.0, hRAR-␣462-FLAG/ PCR3.0, and TTF-1-FLAG/PCR3.0 (positive control) were transiently transfected into H441 cells. Immunohistochemical analysis with an anti-FLAG antibody revealed strong nuclear staining of the FLAG epitope for all three constructs (Fig. 4) . Deletion of the AF-2 and F domains did not change hRAR-␣403 expression and nuclear localization in H441 cells. Untransfected H441 cells did not stain with the anti-FLAG antibody.
DNA binding activity of hRAR-␣403-FLAG on RARE of the hSP-B promoter. Next, in vitro transcribed and translated hRAR-␣462-FLAG and hRAR-␣403-FLAG fusion proteins were assessed for their DNA binding activities. As shown in Fig. 5 , hRAR-␣462-FLAG, hRAR-␣403-FLAG, or hRXR-␥-FLAG fusion protein alone did not form DNA-protein complexes with RARE of the hSP-B promoter. This is due to their low DNA binding affinity. Yan et al. (45) previously reported that when higher concentrations of purified bacteria-expressed hRAR-␥-glutathione S-transferase (GST) fusion protein were used, interaction between hRAR-␥-GST and RARE was observed. In contrast, formation of hRAR-␣462-FLAG/hRXR-␥-FLAG and hRAR-␣403-FLAG/ hRXR-␥-FLAG heterodimers with high DNA binding affinity generated detectable DNA-protein complexes with RARE (Fig. 5) . Binding of hRAR-␣462-FLAG/ hRXR-␥-FLAG and hRAR-␣403-FLAG/hRXR-␥-FLAG complexes with RARE was blocked by the anti-RAR antibody. This is probably due to interference of the RAR antibody with either DNA binding or dimerization of the hRAR-␣403-FLAG/hRXR-␥ or hRAR-␣462-FLAG/ hRXR-␥ heterodimer. Thus, like the wild-type hRAR-␣ in the presence of hRXR, the mutant hRAR-␣403 retained DNA binding activity on RARE of the hSP-B promoter. Nonspecific bands observed in EMSA, which did not contain the hRAR-␣462-FLAG and hRAR-␣403-FLAG fusion proteins, were also detected in the control samples (PCR3.0 empty vector). Nonspecific bands were not changed by the RAR antibody.
Inhibitory effect of hRAR-␣403-FLAG on the hSP-B promoter in H441 cells. Cotransfection of hRAR-␣403-FLAG/PCR3.0 with the hSP-B-500 luciferase reporter gene into H441 cells demonstrated that the mutant hRAR-␣ strongly inhibited luciferase reporter activity (Fig. 6 ). In contrast, the wild-type hRAR-␣ stimulated the hSP-B luciferase reporter gene (45) . The inhibitory effects of the mutant hRAR-␣403 on all trans-RAtreated and untreated hSP-B-500 were dose dependent. Interestingly, the mutant hRAR-␣ did not completely Fig. 2 . Construction of human (h) RAR-␣403-FLAG/PCR3.0 and hRAR-␣403-FLAG/PCR3.0. Full-length hRAR-␣462 and dominant negative hRAR-␣403 lacking ligand-dependent transcriptional activation domain (AF-2) were isolated by PCR and inserted into mammalian cell expression vector PCR3.0. A Kozak sequence was included at the NH 2 terminus, and a FLAG sequence was included at the COOH terminus of hRAR-␣403 and hRAR-␣462. AF-1, ligand-independent transcriptional activation domain; DBD, DNA binding domain; LBD/ dimerization, ligand binding and dimerization domains; F, F domain. Nos. above bars, no. of bp. http://ajplung.physiology.org/ abolish the hSP-B-500 activity. The residual activity of the hSP-B-500 seen in the presence of the mutant hRAR-␣ was similar to that of the basal activity of the hSP-B 218-bp promoter luciferase reporter gene, suggesting that RAR is not required for basal transcription activity of the hSP-B promoter. Therefore, RAR stimulates the hSP-B promoter through RARE located in the upstream enhancer region as previously identified (46) . All trans-RA significantly reversed some of the inhibitory effect of hRAR-␣403. This was probably due to the activation of endogenous RAR. Treatment with 9-cis-RA had the same reversal effect as all trans-RA (data not shown).
Inhibitory effect of hRAR-␣403-FLAG on RA-induced proSP-B production in H441 cells. The effect of hRAR-␣403-FLAG on proSP-B was also examined in H441 cells with double immunofluorescence staining analysis. All trans-RA strongly stimulated proSP-B synthesis in H441 cells as detected by a proSP-B polyclonal antibody (Fig. 7A ), in agreement with previous observations that 9-cis-RA stimulated proSP-B staining in H441 cells (45) . This is also in agreement with the observation that both all trans-RA and 9-cis-RA significantly increased SP-B protein levels in human fetal lung explants (13) . When cells were transfected with hRAR-␣403-FLAG as detected by a FLAG monoclonal antibody, no stimulation of proSP-B by all trans-RA was observed in transfected cells (Fig. 7, B and C) . SP-B mRNA is expressed selectively in bronchiolar and alveolar cells, and its expression is influenced at both the transcriptional and posttranscriptional levels (1, 2, 4, 20, 32-34, 40, 41, 44, 46, 48) . RA stimulates production of SP-B mRNA and increases transcriptional activity (3, 12, 13, 28, 45) . Stimulatory effects of RA are mediated by direct DNA binding of liganded RAR/RXR to an RARE on the hSP-B promoter (45) . One approach to elucidate the biochemical and physiological functions of RAR in the regulation of SP-B gene transcription and homeostasis is to utilize dominant negative RAR derivatives. To further support the notion that RAR is required for full activation of the SP-B promoter, a dominant negative hRAR-␣403-FLAG mutant was generated by deleting the RAR-␣ AF-2 domain (Fig. 2) . The RAR-␣ dominant negative mutant was selected in the present study because immunohistochemical staining indicated expression of RAR-␣ in the fetal lung in vivo (Fig. 1 ) and in respiratory epithelial H441 cells in vitro (45) . It is worthwhile to notice that only a certain population of progenitor epithelial cells was stained with the RAR-␣ antibody. This may imply that this group of progenitor cells will have a different fate during lung differentiation from cells without RAR-␣ expression.
The AF-2 domain of RAR is a ligand-dependent transactivation domain located in the COOH-terminal part of RAR. The AF-2 domain is highly conserved in many members of the nuclear receptor family and is indispensable for the ligand-mediated function. This conserved domain can be swapped between nuclear receptors without affecting the ligand dependency for transactivation (19, 21, 22) . The COOH terminus of the domain (AF-2-AD) forms an amphipathic ␣-helical structure (5). It is proposed that hydrophobic residues of the AF-2-AD helix participate in ligand binding and that the charged residues of the AF-2-AD helix mediate protein-protein interactions with cofactors (see Ref. 16 for a review). Point mutagenesis of the hydrophobic or charged residues of this domain reduced its transactivation activity (11) . After binding to RARE on the target genes, RARs interact with many coactivators (7, 15, 16, 18, 27, 31, 35, 39, 42) . RARs and coactivators synergistically interact with each other to stimulate gene transcription. The AF-2 domain of RAR plays essential roles in mediating protein-protein interaction with coactivators. The present studies demonstrate that deletion of the AF-2 domain abrogated the hRAR-␣ stimulatory effect on the hSP-B promoter, suggesting that the AF-2 domain plays a critical role in activation of the hSP-B promoter in respiratory epithelial cells.
RAR-␣, -␤, and -␥ can be converted into potent dominant negative transcriptional regulators that block the wild-type RAR function by deletion of the AF-2 domain and actively repress the basal transcription level of target promoters (9) . Although deletion of AF-2 domain abrogated RAR transactivation activity of the hSP-B promoter (Fig. 6) , it did not alter DNA binding of http://ajplung.physiology.org/ RAR to RARE of the hSP-B promoter (Fig. 5) . hRAR-␣403 forms an inactive hRAR-␣403/hRXR heterodimer that blocks formation of an active hRAR-␣/hRXR heterodimer to directly inhibit hSP-B gene expression. The inhibitory effect of hRAR-␣403 on the hSP-B promoter might also result from indirect effects. This is evidenced by the observation that all trans-RA significantly reversed the inhibitory effect of hRAR-␣403 on the hSP-B promoter. The mutant RAR-␣ protein was readily detected after transient transfection into H441 cells by immunohistochemical staining (Fig. 4) , suggesting its stability and appropriate translocation to the nucleus.
The finding that the SP-B gene is a downstream target of RAR in pulmonary respiratory epithelial cells is important for understanding the metabolism and homeostasis of SP-B in prenatal and postnatal development of the lung. The function of the newborn lung is dependent on the differentiation of respiratory epithelial cells and the synthesis and secretion of surfactant lipids and proteins into the air space. Pulmonary surfactant is composed of lipids and proteins that reduce surface tension at the air-liquid interface in the alveoli. SPs, including SP-A, SP-B, SP-C, and SP-D, are synthesized primarily by type II or bronchiolar epithelial cells and play critical roles in maintaining stability of the surfactant layer. Lack of pulmonary surfactant leads to alveolar collapse and epithelial cell lysis in respiratory distress syndrome, a major cause of morbidity and mortality in preterm infants. Bronchopulmonary dysplasia (BPD) is a chronic lung disease that often occurs in preterm infants as a result of prolonged and high inspired oxygen concentrations, barotrauma from mechanical ventilation, hyaline membrane disease, and secondary infection with prolonged tracheal intubation. Studies (36) (37) (38) have shown that vitamin A supplementation from the early postnatal period could reduce the morbidity associated with BPD in preterm infants. Studies (45; present study) showed that the vitamin A derivatives RA and RAR stimulate SP-B gene and protein expression in pulmonary epithelial respiratory cells, supporting the recent findings (23, 24) that RA plays a critical role in postnatal alveolarization in vivo.
